RENISHAW PLC (RSW) — Investment Research Note

Executive summary

Renishaw is a UK-based precision engineering group that designs and manufactures measurement sensors (encoders, probes), inspection systems (CMMs, gauging), and specialised technologies (metal additive manufacturing, Raman spectroscopy, neurosurgical robots), with ~96% of revenue outside the UK and manufacturing concentrated in the UK, Ireland and India. The trajectory over the five-year period covered has been a classic cyclical arc — strong FY2022 record, a sharp FY2024 downcycle driven by semiconductor equipment weakness, and a powerful FY2026 rebound (revenue +14% to £815.8m, adjusted operating profit +36% to £152.9m, operating margin 18.7%) with Q4 the strongest quarter in company history 2026-09-23 FY2026 results. The single most important valuation point today is that Renishaw's Position Measurement segment is a direct physical-supply-chain beneficiary of AI-driven semiconductor capex — but the shares, up ~70% in 12 months to 5,650p, now trade near 31x FY2026 adjusted EPS and bake in continued acceleration.

Fair value estimate

Fair value range: 4,900p – 5,700p per share Implied market cap: £3,567m – £4,150m

Methodology: forward-earnings multiple triangulated with through-cycle operating leverage math.

• FY2027 adjusted EPS: estimated 210–230p. FY2026 adjusted EPS was 179.5p; CEO guided "further strong progress on revenue, profit and operating margin" with FY27 starting strongly from the current semi upcycle 2026-09-23 FY2026 results. Group ran at £244m revenue in Q4 FY26 (annualised £976m); even partial sustainment plus the £20m FY26 cost-reduction annualising implies operating profit progression to £180–200m.
• Target multiple: 23–25x. In line with high-quality UK precision engineers with cyclical semiconductor exposure (Spectris historically ~20x, Halma ~27–30x). Semi content and net cash balance sheet justify a modest premium to Spectris; AM/neurological drag and China competition justify a modest discount to Halma.
• Mid-point: ~5,300p / £3,860m market cap.

Comparison vs. £4,336.3m current market cap: implied downside of ~5% to mid-point; range brackets current price (-18% to +4%). The shares look fully priced — not egregiously so, but with no margin of safety for a cyclical.

Sector context

Classification confirmed: Industrials / Industrial Goods and Services (ICB) — specifically precision measurement / electronic & electrical equipment. Listed peers:

• Spectris (SXS) — closest peer; precision instrumentation, similar cyclical exposure.
• Halma (HLMA) — safety and precision sensors; higher margin, more defensive mix.
• Oxford Instruments (OXIG) — scientific/semi instrumentation with similar AI tailwind.

Quality profile is above typical peers on balance sheet (£291m net cash, no financial debt), operating margin trajectory (18.7% rising toward 20%+ target), and R&D intensity (~8% of revenue). It is broadly in line on growth and below on margin resilience — Renishaw's operating leverage cuts both ways through the semi cycle.

Investment thesis

1. Direct AI-receiver via semiconductor equipment encoders. Position Measurement segment grew revenue 26% to £260.9m and operating profit 53% to £71.5m in FY26, "mainly resulting from AI-driven semiconductor manufacturing demand" — the group's encoders are consumed in wafer handling and inspection equipment. Management explicitly calls this "a sweet spot for Renishaw" and FY27 has started strongly on continued semi upcycle demand 2026-09-23 FY2026 results.

2. Operating leverage from a predominantly fixed cost base is now visible. Adjusted operating margin expanded 3.0ppt to 18.7% (5.2ppt at constant currency); FY26 CFO disclosure attributes 4.4ppt of this to operating leverage, with incremental revenue absorbing fixed engineering, distribution and administrative costs 2026-09-23 FY2026 results. The £20m FY25 cost-reduction programme now fully in run-rate contributed another 2.5ppt. Management targets 20%+ operating margin — plausibly reachable without heroic growth.

3. Fortress balance sheet funding capacity expansion and shareholder returns. £291m cash and deposits, net cash position, ROIC 17.5% (up from 13.2%). Group has committed to encoder capacity expansion (short-term payback), and declared both a 5% ordinary dividend increase and a 70p special dividend (£51m) — signalling confidence in through-cycle cash generation 2026-09-23 FY2026 results.

Key risks

1. Semiconductor cycle rollover. Management acknowledges "the semiconductor market undergoes multi-year business cycles" 2026-09-23 FY2026 results. Position Measurement is now 32% of revenue and the largest profit contributor; a semi correction (as happened in FY24, when PM revenue fell and encoder demand collapsed) would unwind the recent profit uplift sharply given operating leverage works in reverse.

2. Chinese low-price competition and market-access risk. Risk rating increased in FY26; CEO notes "rising competition, particularly in China, from rivals offering 'good enough' products at attractive prices" and the group is now developing "entry-level" products — a margin-dilutive response 2026-09-23 FY2026 results. China is 27% of revenue (£220m).

3. IT transformation / Microsoft D365 deployment paused. Management "paused the rollout" after deployment challenges, engaging third-party advisers; disruption to the FY26 EMEA sales ERP contributed to H1 regional softness 2026-09-23 FY2026 results, 2026-02-11 H1 report. Execution risk is live and productivity benefits deferred.

Operating leverage

Renishaw is a classic high-fixed-cost precision engineer with meaningful but not extreme operating leverage. Gross margin (ex engineering) is 59.6%, with gross engineering expenditure of £113.9m (14% of revenue), distribution £159.5m and administrative £80.9m — the bulk of these costs are substantially fixed in the medium term. FY26 demonstrates the mechanics: revenue grew 14.4% but adjusted operating profit grew 36.2% (and 63% at constant currency), with 4.4ppt of margin expansion directly attributable to operating leverage per the CFO 2026-09-23 FY2026 results. A further 10–20% revenue beat on current £816m base — plausible if the semi upcycle extends and additive manufacturing continues scaling — would, at ~55% contribution margin on incremental sales, add roughly £45–90m to operating profit, i.e. +30% to +60% on FY26's £152.9m. Specialised Technologies offers additional torque: it moved from a £9.9m loss to a £4.7m profit on 43% revenue growth, with every product line now profitable 2026-09-23 FY2026 results. The constraint is encoder manufacturing capacity, which the company is actively expanding "with a short-term payback". Downside leverage is symmetric: a 15% revenue decline (such as FY24's shortfall from peak) would likely halve profit.

Value-trap signals

None identified. On the contrary — rising revenue, expanding margins, net cash balance sheet, growing dividend, no accounting flags, clean cash conversion (79%, above 70% target), and management actively exiting non-core (drug delivery, neurosurgical disposals in progress). Executive Chairman family ownership restructured into Deltam Holdings in Nov 2025 but with no change in control intent 2026-09-23 FY2026 results. Richard McMurtry (son of the late co-founder) joined the Board as a non-executive in July 2024.

Earnings vs. expectations

Across the covered period Renishaw has shown a pattern of conservative initial guidance followed by progressive upgrades. FY2026 is illustrative: H1 guidance (Feb 2026) was revenue £740–780m / adj PBT £132–157m 2026-02-11 half-year report; raised in April to £775–805m / £145–165m 2026-04-20 trading statement; delivered £815m / £168m 2026-07-24 trading statement, 2026-09-23 FY2026 results — top-end+ beats on both metrics. FY2025 was the opposite case — H1 2025 guidance of £695–735m revenue / £105–135m adj PBT was tightened downward in May 2025 (£700–720m / £109–127m) 2025-05-08 trading statement and delivered at £713m / £127m. Overall: more beats than misses in the current cycle, with the pattern typical of UK industrials — guide prudently, raise on positive surprises.

Conviction

Conviction: 4 (high).

Supporting factors: (i) clean, well-disclosed statutory financials with adjusted/statutory reconciliations; (ii) multiple valuation approaches (forward PE, through-cycle operating profit) land in overlapping ranges; (iii) 5-year disclosure track record is consistent and auditor reports clean. Limiting factors: (i) earnings are at a cyclical high and FY27 EPS estimate is the single largest sensitivity — a semi correction could move fair value 20%+ lower; (ii) the premium multiple requires sustained execution against Chinese competition and additive manufacturing scaling, both of which carry asymmetric downside.

Driver scoring

• ai_beneficiary: 72 — Position Measurement segment (32% of revenue, growing 26%+) is a direct AI-capex beneficiary via semiconductor equipment encoders; management explicitly ties growth to AI-driven semi demand. Industrial Metrology (55% of revenue) is only indirect. Not a pure-play, but a genuine physical-supply-chain receiver.
• operating_leverage: 68 — Demonstrated 4.4ppt margin expansion from operating leverage in FY26 on 14% revenue growth; largely fixed engineering and admin cost base. Not a software-level 80+, but above typical industrials.
• earnings_surprise_trend: 70 — Pattern of upgrading guidance through FY26 and beating consensus; FY25 had modest downgrades but also delivered within. More beats than misses.
• cyclicality: 65 — Significant exposure to semiconductor capex cycle, machine tool investment, aerospace — FY24 downturn demonstrated vulnerability.
• moat: 68 — Patent portfolio, deep precision-engineering expertise, long customer relationships, manufacturing scale. Not a durable network-effect moat but durable technical/IP advantage.
• leverage: 8 — Net cash of £289m, trivial borrowings (£2m). Fortress balance sheet.
• earnings_quality: 78 — Clean adjusted/statutory reconciliation, 79% cash conversion, unqualified audits. One-off adjustments (£18m in FY26) are well-disclosed and genuine.
• management_quality: 70 — Long tenure, consistent capital allocation, in-sourcing R&D and manufacturing. Founder Sir David McMurtry died in Dec 2024; new CFO in H2 FY26; some execution questions on D365 IT programme.
• growth_momentum: 78 — FY26 revenue +14% actual / +17% constant currency; Q4 up 28%; FY27 "started strongly"; order book at record. 5-year through-cycle CAGR 8% and accelerating.

Overall score: 650

Renishaw is a legitimate AI-receiver with real operating leverage and a fortress balance sheet — this hits all three investor pillars at some level. But the current price (31x FY26 adjusted EPS, 25x likely FY27) requires the semi upcycle to continue and operating leverage to progress toward the 20% margin target. It is "right idea, available at a fair price" rather than a bargain. Downside protection is excellent; AI exposure is partial not pure; valuation is full. Falls into upper end of the 600–799 "strong buy with reservations" band.